Radiopharm Entitlement Offer
Radiopharm Therapeutics CEO, Riccardo Caneveri, introduces the Non-Renounceable Entitlement Offer to raise approximately $10 million. Eligible shareholders in Australia and New Zealand will be invited to participate in the Entitlement Offer which will open on Wednesday, 8 November 2023 and close at 5:00pm (Sydney time) on Friday, 24 November 2023.
For more information, visit Radiopharm’s dedicated Entitlement Offer website.
